EGFR exon 20 insertion A763-Y764insFQEA and response to erlotinib-letter

Molecular Cancer Therapeutics

Volumn 12, Issue 11, 2013, Pages 2614-2615

  Voon, Pei Jye ^a   Tsui, Dana Wai Yi ^c   Rosenfeld, Nitzan ^c   Chin, Tan Min ^a,b  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ERLOTINIB; GEMCITABINE; NAVELBINE; THYROID TRANSCRIPTION FACTOR 1;

AGED; CANCER GROWTH; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REDUCTION; EXON; FINE NEEDLE ASPIRATION BIOPSY; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; HUMAN; LETTER; LUNG NON SMALL CELL CANCER; MALE; MONOTHERAPY; PRIMARY TUMOR; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SKIN TOXICITY; TREATMENT RESPONSE;

ADENOCARCINOMA; EXONS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MUTAGENESIS, INSERTIONAL; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84887462619     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-13-0041     Document Type: Letter

References (5)

1. Arcila ME, Nafa K, Chaft JE, Rekhtman N, Lau C, Reva BA, et al. EGFR exon 20 insertion mutations in lung adenocarcinomas: prevalence, molecular heterogeneity, and clinicopathologic characteristics. Mol Cancer Ther 2013;12:220-9.
2. Yasuda H, Kobayashi S, Costa DB. EGFR exon 20 insertion mutations in non-small-cell lung cancer: preclinical data and clinical implications. Lancet Oncol 2012;13:e23-31.
3. Chin TM, Anuar D, Soo R, Salto-Tellez M, Li WQ, Ahmad B, et al. Detection of epidermal growth factor receptor variations by partially denaturing HPLC. Clin Chem 2007;53: 62-70.
4. Yeo WL, Riely GJ, Yeap BY, Lau MW, Warner JL, Bodio K, et al. Erlotinib at a dose of 25 mg daily for non-small cell lungancers with EGFR mutations. J Thorac Oncol 2010;5:1048-53.
5. Forshew T, MurtazaM, Parkinson C, Gale D, Tsui DW, Kaper F, et al. Noninvasive identification and monitoring of cancerutations by targeted deep sequencing of plasma DNA. Sci Transl Med 2012;4: 136ra68.